Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New GABA(A) receptor agonists described by Sumitomo Dainippon Pharma

Oct. 11, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent AKT1/AKT2/AKT3 inhibitors

Oct. 11, 2021

Enanta Pharmaceuticals synthesizes new anti-HBV compounds

Oct. 11, 2021

Sichuan Haisco Pharmaceutical describes new JAK inhibitors

Oct. 8, 2021

Merck KGaA and Ryvu Therapeutics divulge new ACSS2 inhibitors

Oct. 8, 2021

Evotec presents ISR pathway modulators

Oct. 8, 2021

Minghui Pharmaceutical scientists synthesize new JAK inhibitors

Oct. 8, 2021

AstraZeneca patents SLC12A5 activators

Oct. 8, 2021

Verge Analytics discovers new PIKfyve inhibitors

Oct. 7, 2021

Researchers synthesize new CDK inhibitors

Oct. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.